ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 135 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 2.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $44,371,000 | -27.0% | 2,133,222 | +15.0% | 0.01% | -33.3% |
| Q3 2016 | $60,787,000 | +38.8% | 1,854,944 | +5.7% | 0.01% | +20.0% |
| Q2 2016 | $43,810,000 | +57.4% | 1,754,513 | +54.3% | 0.01% | +66.7% |
| Q1 2016 | $27,841,000 | -22.7% | 1,136,823 | +4.2% | 0.01% | -25.0% |
| Q4 2015 | $36,033,000 | -6.3% | 1,090,915 | -7.0% | 0.01% | -20.0% |
| Q3 2015 | $38,449,000 | -25.8% | 1,173,654 | +19.9% | 0.01% | -16.7% |
| Q2 2015 | $51,838,000 | +138.0% | 978,637 | +29.7% | 0.01% | +140.0% |
| Q1 2015 | $21,777,000 | +28.3% | 754,562 | +29.3% | 0.01% | +25.0% |
| Q4 2014 | $16,976,000 | +608.2% | 583,582 | +208.7% | 0.00% | +300.0% |
| Q3 2014 | $2,397,000 | -39.3% | 189,069 | -4.0% | 0.00% | 0.0% |
| Q2 2014 | $3,952,000 | – | 196,908 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,628,328 | $33,869,000 | 14.72% |
| Foresite Capital Management II, LLC | 995,396 | $20,704,000 | 10.39% |
| Cormorant Asset Management, LP | 1,581,604 | $32,897,000 | 4.43% |
| DAFNA Capital Management LLC | 221,013 | $4,597,000 | 4.04% |
| New Leaf Venture Partners, L.L.C. | 228,428 | $4,751,000 | 3.40% |
| Partner Investment Management, L.P. | 63,571 | $1,322,000 | 1.75% |
| Iguana Healthcare Management, LLC | 140,000 | $2,912,000 | 1.74% |
| PFM Health Sciences, LP | 2,913,951 | $60,610,000 | 1.71% |
| Redmile Group, LLC | 920,550 | $19,147,000 | 1.65% |
| SECTORAL ASSET MANAGEMENT INC | 669,351 | $13,923,000 | 1.54% |